It is difficult to put a dollar figure on how far the commercialization of iPS would boost economic activity, but, in the first instance, by being able to trade iPS blood between organizations, instead of produce it on site, it is expected that research activities, such as those involving drug discovery, will accelerate, possibly feeding into greater and more rapid commercial application.